Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Hepatology
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: sitagliptin, non-alcoholic fatty liver disease, DPP-4 inhibitors, liver fat, proton density fat fraction, liver fibrosis, prediabetes, diabetes mellitus, insulin resistance, alanine aminotransferase, magnetic resonance elastography, MR spectroscopy, liver histopathology, liver stiffness, drug safety
Open Access status: green
OpenAlex ID: W2397785404
